Two-thirds of COPD hospitalized patients misuse inhalers
Aug 23, 2024
Most misuse inhalers were due to a critical error in the inhalation technique.
Clinical quality up at hospitals with research publications
Mar 04, 2022
Hospital research publications were linked to lower risk-adjusted mortality rates for several conditions and procedures as well as higher patient satisfaction.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
CAPTURE screening tool has high specificity for identifying COPD
Feb 14, 2023
The tool has a sensitivity of 48.2% and a specificity of 88.6% for identifying undiagnosed, clinically significant COPD.
Generic, brand-name medication similarly effective for COPD
Aug 07, 2023
Wixela Inhub and Advair Diskus fluticasone-salmeterol are similarly effective and safe for chronic obstructive pulmonary disease.
Race-neutral metrics more accurately predict risk in COPD
May 31, 2024
The GLI-Global differentiated all-cause mortality risk between normal spirometry and first grade of COPD in adjusted analyses.
Bisoprolol does not reduce exacerbations in at-risk COPD patients
May 20, 2024
No reduction was seen in the number of self-reported exacerbations treated with oral corticosteroids, antibiotics or both.
Acute hospital care at home shows promise for medically complex patients
Jan 08, 2024
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
Dupilumab tied to fewer exacerbations in COPD with type 2 inflammation
May 21, 2024
An increase was seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12 and 52.
Pulmonologist intervention beneficial for undiagnosed asthma, COPD
May 21, 2024
Those receiving pulmonologist-directed treatment have less subsequent healthcare utilization for respiratory illness.
